APL-1

N/A

Report date: 2021/12/14 07:28:01

Base Information

Drug NameAPL-1
Drug Alias NameAPL-1
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionComplement C3 inhibitors
TargetsComplement C3
Therapy Area/IndicationsHemoglobinuria, Paroxysmal
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesApellis Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesApellis Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsHemoglobinuria, Paroxysmal

Other Information

ATC CodeN/A
Related LinksN/A